FIBROSIS INHIBITOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100172913A1
SERIAL NO

12663420

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An objective of the present invention is to provide methods for treating or preventing fibrotic diseases, which are based on the novel finding that fibrosis is suppressed by administering ER-TR7 to a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STELIC INSTITUTE OF REGENERATIVE MEDICINE STELIC INSTITUTE & COTOKYO 106-0044

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Yoneyama, Hiroyuki Minato-ku, JP 177 1018

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation